Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 20/20 | 0.62 |
| ▸ | BRD2 | P25440 | 4/20 | 0.46 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.43 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.43 |
| ▸ | TAF1 | P21675 | 1/20 | 0.43 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.43 |
| ▸ | EP300 | Q09472 | 1/20 | 0.43 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.43 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.43 |
| ▸ | CECR2 | Q9BXF3 | 1/20 | 0.43 |
| ▸ | BRD8 | Q9H0E9 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31735607 | 0.84 | BRD4 (0.51) | BRD4BRD2CREBBP | |
| SCHEMBL31735473 | 0.81 | BRD4 (0.49) | BRD4BRD2CREBBP | |
| SCHEMBL17698675 | 0.81 | BRD4 (0.61) | BRD4BRD2CREBBPTRIM24TAF1 | |
| SCHEMBL31735538 | 0.81 | BRD4 (0.52) | BRD4BRD2CREBBP | |
| SCHEMBL31735368 | 0.80 | BRD4 (0.54) | BRD4BRD2CREBBPTRIM24TAF1 | |
| SCHEMBL31735866 | 0.78 | BRD4 (0.48) | BRD4BRD2CREBBPBRD3 | |
| SCHEMBL31735576 | 0.78 | BRD4 (0.52) | BRD4BRD2CREBBP | |
| SCHEMBL31735822 | 0.78 | CYP3A4 (0.55) | BRD4 | |
| SCHEMBL31735594 | 0.78 | BRD4 (0.46) | BRD4BRD2CREBBP | |
| SCHEMBL30231173 | 0.77 | BRD4 (0.65) | BRD4BRD2CREBBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025245484-A1 | FOXN1 ACTIVATORS | THYMOFOX INC. (US) | 2025-11-27 | — | — | WO | disclosed |